Julia has extensive commercial experience at executive and director level in both start-up and corporate organizations in the fields of Biopharmaceuticals and medical technology. She brings a strong background in business development, strategy, and capital raising, across Asia Pacific, North America and Europe.
Previous roles include: Senior Director, Corporate Development for Genzyme (now a Sanofi company); Head of Corporate Development for Adherium, plus various commercial roles at Eli Lilly.
Julia currently holds a number of strategic commercial advisory and governance roles with high growth technology companies in various sectors including medical devices, biotechnology, smart infrastructure and food/agritech sectors. In addition to these roles, Julia also serves on the New Ventures Advisor Board for Beca and is a mentor on their corporate accelerator programme. She also sits on a number of technology venture investment committees.
Julia is passionate about helping high growth technology companies and innovative businesses to thrive on the global stage and investing in the future of a diversified New Zealand economy by nurturing start-ups and the next generation of world-class entrepreneurs.